Tamiya, Motohiro
Tamiya, Akihiro
Hosoya, Kazutaka
Taniguchi, Yoshihiko
Yokoyama, Toshihide
Fukuda, Yasushi
Hirano, Katsuya
Matsumoto, Hirotaka
Kominami, Ryota
Suzuki, Hidekazu
Hirashima, Tomonori
Uchida, Junji
Morita, Mitsunori
Kanazu, Masaki
Sawa, Nobuhiko
Kinoshita, Yoshinori
Hara, Satoshi
Kumagai, Toru
Fujimoto, Daichi
Article History
Received: 22 July 2019
Accepted: 26 July 2019
First Online: 7 August 2019
Compliance with ethical standings
:
: Drs. M. Tamiya, A. Tamiya, Fujimoto, Hirano, and Kumagai have received lecture fees from Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan) and Merck Sharp & Dohme, Corp. (Tokyo, Japan). Drs. Yokoyama and Hirashima have received lecture fees from Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan). Drs. Taniguchi, Ishida and Kanazu have received lecture fees from Merck Sharp & Dohme, Corp. (Tokyo, Japan). The remaining authors have no conflicts of interest to declare.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: For this type of study, formal consent is not required.